Oxidative stress detection: Whar for? Part II

European Review for Medical and Pharmacological Sciences

Volumn 11, Issue 1, 2007, Pages 27-54

  Palmieri, Beniamino ^a   Sblendorio, V ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Antioxidants; Free radicals; Oxidative stress; RNS; ROS

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CARBOGEN; CEFTRIAXONE; CLARITIN D; ESTRADIOL; ESTRIOL; ESTROGEN; GLUTATHIONE; GLYCYRRHIZIC ACID; MAGNESIUM; NORPHENAZONE; ORAL CONTRACEPTIVE AGENT; OXYGEN RADICAL; PLACEBO; PLANT EXTRACT; PORPHYRIN DERIVATIVE; RALOXIFENE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SCHISANDRA EXTRACT; SILYMARIN; STEROID; TETRAKIS(4 BENZOIC ACID)PORPHYRIN MANGANESE; THIOCTIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN B COMPLEX; ZINC;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLERGY; ALZHEIMER DISEASE; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENDOMETRIOSIS; ESTROGEN ACTIVITY; GLOMERULOPATHY; HEARING LOSS; HEART PROTECTION; HELICOBACTER INFECTION; HERNIOPLASTY; HORMONAL THERAPY; HUMAN; HYPERTENSION; IMMUNE MEDIATED INJURY; INFLAMMATION; INGUINAL HERNIA; KIDNEY DISEASE; KIDNEY INJURY; LIVER DISEASE; MALE INFERTILITY; MENOPAUSAL SYNDROME; NEUROPROTECTION; NONHUMAN; ORAL CONTRACEPTION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PERENNIAL RHINITIS; PREECLAMPSIA; PREGNANCY; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SURGICAL PATIENT; THROMBOSIS; THYROID DISEASE; TISSUE INJURY; VIRUS HEPATITIS; VIRUS INFECTION;

ANIMALS; ANTIOXIDANTS; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 33947643613     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (192)

1. Krishna MT, Chauhan AJ, Frew AJ, Holgate ST. Toxicological mechanisms underlying oxidant pollutant-induced airway injury. Rev Environ Health 1998; 13: 59-71.
2. Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001; 7: 1-7.
3. Katsoulis K, Kontakiotis T, Baltopoulos G, Kotsovili A, Legakis IN. Total antioxidant status and severity of community-acquired pneumonia: are they correlated? Respiration 2005; 72: 381-387.
4. Guenegou A, Leynaert B, Pin I, Le Moel G, Zureik M, Neukirch F. Serum carotenoids, vitamins A and E, and 8 year lung function decline in a general population. Thorax 2006; 61: 320-326.
5. Henricks PA, Nukamp FP. Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther 2001; 14: 409-420.
6. Comhair SA, Brathena PR, Dweik RA, Kavuru M, Erzurum SC. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet 2000; 355: 624.
7. Patel BD, Welch AA, Bingham SA, Luben RN, Day NE, Khaw KT, Lomas DA, Wareham NJ. Dietary antioxidants and asthma in adults. Thorax 2006; 61: 388-393.
8. Naito Y, Takano H, Yoshikawa T. Oxidative stress-related molecules as a therapeutic target for inflammatory and allergic diseases. Curr Drug Targets Inflamm Allergy 2005; 4: 511-515.
9. Montano Velazquez BB, Jauregui-Renaud K, Banuelos Arias Adel C, Ayala JC, Martinez MD, Campillo Navarrete R, Rosalia IS, Salazar Mdel R, Serrano HA, Mondragon AO, Perez RL. Vitamin E effects on nasal symptoms and serum specific IgE levels in patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol 2006; 96: 45-50.
10. Cerda B, Soto C, Albaladejo MD, Martinez P, Sanchez-Gascon F, Tomas-Barberan F, Espin JC. Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 2006; 60: 245-253.
11. Stehbens WE. Oxidative stress in viral hepatitis and AIDS. Exp Mol Pathol 2004; 77: 121-132.
12. Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab 2006; 50: 85-94.
13. Melhem A, Stern M, Shibolet O, Israeli E, Ackerman Z, Pappo O, Hemed N, Rowe M, Ohana H, Zabrecky G, Cohen R, Ilan Y. Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol 2005; 39: 737-742.
14. Caraceni P, Ryu HS, Subbotin V, De Maria N, Colantoni A, Roberts L, Trevisani F, Bernardi M, Van Thiel DH. Rat hepatocytes isolated from alcohol-induced fatty liver have an increased sensitivity to anoxic injury. Hepatology 1997; 25: 943-949.
15. Rouach H, Fataccioli V, Gentil M, French SW, Morimoto M, Nordmann R. Effect of chronic ethanol feeling on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology 1997; 25: 351-355.
16. Tanner AR, Bantock I, Hinks LM, Lloyd B, Turner NR, Wright R. Depressed selenium and vitamin E levels on alcoholic population: possible relationship to hepatic injury through increased lipid peroxidation. Dig Dis Sci 1986; 31: 1307-1312.
17. Shaw S, Rubin KP, Lieber CS. Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease, evidence of lipid peroxidation. Dig Dis Sci 1983; 28:585-589.
18. Addolorato G, Gasbarrini A, Marcoccia S, Simoncini M, Baccarini P, Vagni G, Grieco A, Sbriccoli A, Granato A, Stefanini GF, Gasbarrini G. Prenatal exposure to ethanol in rats: effects on liver energy level and antioxidant status in mothers, fetuses and newborns. Alcohol 1997; 14: 569-573.
19. Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, Hunter DJ, Hankinson SE, Hennekens CH, Rosner B. Alcohol consumption and mortality among women. N Engl J Med 1995; 332: 1245-1250.
20. Klatsky AL, Armstrong MA, Friedman GD. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and non-drinkers. Am J Cardiol 1990; 66: 1237-1242.
21. Sacco RL, Elkind M, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999; 281: 53-60.
22. Muntwyler J, Hennekens CH, Buring JE, Graziano JM. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet 1998; 352: 1882-1885.
23. Gasbarrini A, Pasini P, Nardo B, De Notariis S, Simoncini M, Cavallari A, Roda E, Bernardi M, Roda A. Chemiluminescent real time imaging of post-ischemic oxygen free radicals formation in liver isolated from young and old rats. Free Radic Biol Med 1998; 24: 211-216.
24. Gasbarrini A, Colantoni A, Di Campli C, De Notariis S, Masetti M, Iovine E, Mazziotti A, Massari I, Gasbarrini G, Pola P, Bernardi M. Intermittent anoxia reduces oxygen free radicals formation during reoxygenation in rat hepatocytes. Free Radic Biol Med 1997; 23: 1067-1072.
25. Gasbarrini A, Simoncini M, Di Campli C, De Notariis S, Colantoni A, Pola P, Bernardi M, Gasbarrini G. Ageing affects anoxia-reoxygeneration injury in rat hepatocytes. Scand J Gastroenterol 1998; 33: 1107-1112.
26. Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med 1988; 319: 1639-1650.
27. Lieber CS. Role of oxidative stress and antioxidant therapy in alcoholic and non-alcoholic liver diseases. Adv Pharmacol 1997; 38: 601-628.
28. Lieber CS. Biochemical mechanisms of alcoholic-induced hepatic injury. Alcohol Alcoholism 1991: 283-290.
29. Nordmann R, Ribière C, Roauch H. Implication of free radical mechanisms in ethanol induced cellular injury. Free Radic Biol Med 1992; 12: 219-240.
30. Garcia-Ruiz C, Morales A, Ballesta A, Rodes J, Kaplowitz N, Fernandez-Checa JC. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. J Clin Invest 1994; 94: 193-201.
31. Fernandez-Checa JC, Garcia-Ruiz C, Ookhtens M, Kaplowitz N. Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress. J Clin Invest 1991; 87: 397-405.
32. Lauterburg BH, Davies S, Mitchell JR. Ethanol suppress hepatic glutathione synthesis in rats in vivo. J Pharmacol Exp Ther 1984; 230: 7-11.
33. Caraceni P, De Maria N, Ryu HS, Colantoni A, Roberts L, Maidt ML, Pye Q, Bernardi M, Van Thiel DH, Floyd RA. Proteins but not nucleic acids are molecular targets for free radical attack during reoxygenation of rat hepatocytes. Free Radic Biol Med 1997; 23: 339-344.
34. Addolorato G, Di Campli C, Simoncini M, Pasini P, Nardo B, Cavallari A, Pola P, Roda A, Gasbarrini G, Gasbarrini A. Oxygen free radical production in rat liver: dose-related effect of ethanol on reperfusion injury. Dig Dis Sci 2001; 46: 1057-1066.
35. Te Sligte K, Bourass I, Sels JP, Driessen A, Stockbrugger RW, Koek GH. Non-alcoholic steatohepatitis: review of a growing medical problem. Eur J Intern Med 2004; 15: 10-21.
36. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
37. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary on AASLD Single Topic Conference. Hepatology 2003; 37: 1202-1219.
38. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474.
39. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullogh AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419.
40. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669.
41. Green RM. NASH-hepatic metabolism and not simply the metabolic syndrome. Hepatology 2003; 38: 14-17.
42. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steato-hepatitis. Proc Natl Acad Sci USA 1997; 94: 2557-2562.
43. Chiturri S, Farrell GC. Etiopathogenesis of nonalcolic steato-hepatitis. Semin Liver Dis 2001; 21: 27-41.
44. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845.
45. Videla LA, Rodrigo RN, Araya J, Poniachik J. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic Biol Med 2004; 37: 1499-1507.
46. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 2002; 283: 256-265.
47. Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002; 27: 63-68.
48. Bhat VB, Madyastha KM. Antioxidant and radical scavenging properties of 8-oxo-derivates of xanthine drugs pentoxifylline and lisofylline. Biochem Biophys Res Commun 2001; 288: 1212-1217.
49. Leclerco IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine non-alcoholic steatohepatitis. J Clin Invest 2000; 105: 1067-1075.
50. Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-beta I level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 2001; 15: 1667-1672.
51. Sanyal AJ, Mofrad PS, Contos MJ, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, Shiffman ML, Clore J, Mills AS. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2004; 2: 1107-1115.
52. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003; 98: 2485-2490.
53. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222: 222-235.
54. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285.
55. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119.
56. Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab 2004; 34: 57-62.
57. Fierbinteanu-Braticevici C, Bengus A, Neamtu M, Usvat R. The risk factors of fibrosis in nonalcoholic steatohepatitis. Rom J Intern Med 2002; 40: 81-88.
58. Videla LA, Rodrigo R, Orellana M, Fernandez V, Tapia G, Quinones L, Varela N, Contreras J, Lazarte R, Csendes A, Rojas J, Maluenda F, Burdiles P, Diaz JC, Smok G, Thielemann L, Poniachik J. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci 2004; 106: 261-268.
59. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998; 115: 642-648.
60. Mobley HL. Helicobacter pylori factors associated with disease development. Gastroenterology 1997; 113: 21-28.
61. Davies GR, Simmonds NJ, Stevens TR, Sheaff MT, Banatvala N, Laurenson IF, Blake DR, Rampton DS. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179-185.
62. Nielsen H, Andersen LP. Activation of human phagocyte oxidative metabolism by Helicobacter pylori. Gastroenterology 1992; 103: 1747-1753.
63. Zhang QB, Nakashabendi IM, Mokhashi MS, Dawodu JB, Gemmell CG, Russell RI. Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 1996; 38: 841-845.
64. Davies GR, Banatvala N, Collins CE, Sheaff MT, Abdi Y, Clements L, Rampton DS. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 1994; 29: 419-424.
65. Davies GR, Rampton DS. Helicobacter pylori, free radicals and gastroduodenal disease. Eur J Gastroenetrol Hepatol 1994; 6: 1-10.
66. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.
67. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull 1993; 49: 481-493.
68. Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, Lindley IJ, Rappuoli R. Helicobacter pylori induced interleukin-8 expression in gastric hepithelial cells is associated with CagA positive phenotype. J Clin Pathol 1995; 48: 41-45.
69. Crabtree JE. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 1996; 10: 29-37.
70. Guslandi M. A radical view of Helicobacter pylori. Am J Gastroenterol 1999; 94: 2797-2798.
71. Danese S, Cremonini F, Armuzzi A, Candelli M, Papa A, Ojetti V, Pastorelli A, Di Caro S, Zannoni G, De Sole P, Gasbarrini G, Gasbarrini A. Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa. Scand J Gastroenterol 2001; 36: 247-250.
72. Modzelewski B. Antioxidative barrier activity assessment in gastro-esophageal reflux disease. Wiad Lek 2004; 57: 603-606.
73. Polat C, Kahraman A, Yilmaz S, Koken T, Serteser M, Akbulut G, Arikan Y, Dilek ON, Gokce O. A comparison of the oxidative stress response and antioxidant capacity of open and laparoscopic hernia repairs. J Laparoendosc Adv Surg Tech A 2003; 13: 167-173.
74. Fuchs J, Emerit I, Levy A, Cernajvski L, Schofer H, Milbradt R. Clastogenic factors in plasma of HIV-1 infected patients. Free Radic Biol Med 1995; 19: 843-848.
75. Mapp PI, Grootveld MC, Blake DR. Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 1995; 51: 419-436.
76. Maurice MM, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F, Lechner S, van der Voort EA, Leow A, Versendaal J, Muller-Ladner U, Yodoi J, Tak PP, Breedveld FC, Verweij CL. Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 1999; 42: 2430-2439.
77. Arii K, Kumon Y, Ikeda Y, Suehiro T, Hashimoto K. Edaravone inhibits the disease activity in rheumatoid arthritis. J Clin Pharm Ther 2006; 31: 197-199.
78. Maurizi CP. Could antioxidant therapy reduce the incidence of deafness following bacterial meningitis? Med Hypotheses 1999; 52: 85-87.
79. Klein M, Koedel U, Pfister HW, Kastenbauer S. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy. Ann Neurol 2003; 54: 451-458.
80. Coling DE, Yu KC, Somand D, Satar B, Bai U, Huang TT, Seidman MD, Epstein CJ, Mhatre AN, Lalwani AK. Effect of SOD1 overexpression on age- and noise-related hearing loss. Free Radic Biol Med 2003; 34: 873-880.
81. Joachims HZ, Segal J, Golz A, Netzer A, Goldenberg D. Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol 2003; 24: 572-575.
82. Banfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, Krause KH. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 2004; 279: 46065-46072.
83. Carlsson PI, Van Laer L, Borg E, Bondeson ML, Thys M, Fransen E, Van Camp G. The influence of genetic variation in oxidative stress genes on human noise susceptibility. Hear Res 2005; 202: 87-96.
84. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, Radella F, Garcia I, Maier RV. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236: 814-822.
85. Mishra V, Baines M, Wenstone R, Shenkin A. Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem 2005; 42: 269-276.
86. Biondi C, Pavan B, Lunghi L, Fiorini S, Vesce F. The role and modulation of the oxidative balance in pregnancy. Curr Pharm Des 2005; 11: 2075-2089.
87. Dotsch J, Hogen N, Nyul Z, Hanze J, Knerr I, Kirschbaum M, Rascher W. Increase of endothelial nitric oxide synthase and endothelin-1 mRNA expression in human placenta during gestation. Eur J Obstet Gynecol Reprod Biol 2001; 97: 163-167.
88. Lachili B, Hininger I, Faure H, Arnaud J, Richard MJ, Favier A, Roussel AM. Increased lipid peroxidation in pregnant women after iron and vitamin C supplementation. Biol Trace Elem Res 2001; 83: 103-110.
89. Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 2004; 11: 342-352.
90. Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 2005; 60: 807-816.
91. Giudice LC, Kao LC. Endometriosis. Lancet 2004; 364: 1789-1799.
92. Van Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril 2002; 77: 861-870.
93. Vinatier D, Cosson M, Dufour P. Is endometriosis an endometrial disease? Eur J Obstet Gynecol Reprod Biol 2000; 91: 113-25.
94. Pellicer A, Oliveira N, Ruiz A, Remohi J, Simon C. Exploring the mechanism(s) of endometriosis-related infertility: an analysis of embryo development and implantation in assisted reproduction. Hum Reprod 1995; 10: 91-97.
95. Klein SL, Carnovale D, Burnett AL, Wallach EE, Zacur HA, Crone JK, Dawson VL, Nelson RJ, Dawson TM. Impaired ovulation in mice with targeted deletion of the neuronal isoform of nitric oxide synthase. Mol Med 1998; 4: 658-664.
96. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002; 288: 980-987.
97. Bushnell CD. Oestrogen and stroke in women: assessment of risk. Lancet Neurol 2005; 4: 743-751.
98. Mano T, Shinohara R, Iwase K, Kotake M, Hamada M, Uchimuro K, Hayakawa N, Hayashi R, Nakai A, Ishizuki Y, Nagasaka A. Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm Metab Res 1997; 29: 351-354.
99. Freedman RR. Biochemical, metabolic, and vascular mechanisms in menopausal hot flushes. Fertil Steril 1998; 70: 332-337.
100. Subbiah MTR. Mechanisms of cardioprotection by estrogens. Proc Soc Exper Biol Med 1998; 217: 23-29.
101. Ayers S, Tang M, Subbiah MTR. Estradiol 17-b as an antioxidant distinct features when compared to other fat soluble antioxidants. J Lab Clin Med 1996; 128: 367-375.
102. Shwaery GT, Vita GA, Keaney JF Jr. Antioxidant protection of LDL by physiological concentrations of 17 β-estradiol. Requirement for estradiol modification. Circulation 1997; 95: 1378-1385.
103. Koh K. Effects of estrogen on the vascular wall: vasomotor function and inflammation. Cardiovasc Res 2002; 55: 714-726.
104. Falkeborn M, Lithell H, Persson I, Vessby B, Maessen T. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial. Climacteric 2002; 5: 240-248.
105. Hernandez I, Delgado JL, Diaz J, Quesada T, Teruel MJ, Llanos MC, Carbonell LF. 17 b-estradiol prevents oxidative stress and decrease blood pressure in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 2000; 279: 1599-1605.
106. Montilla P, Tunez MC, Delgado MJ, Salcedo M. Hyperlipidemic nephropathy induced by adriamycin in ovariectomized rats: role of free radicals and effect of 17-beta-estradiol administration. Nephron 2000; 85: 65-70.
107. Tikkanen MJ, Vihma V, Hockerstedt A, Jauhiainen M, Helisten H, Kaamanen M. Lipophilic oestrogen derivatives contained in lipoprotein particles. Acta Physiol Scand 2002; 176: 117-121.
108. Inestrosa NC, Marzolo MP, Bonnefont AB. Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease. Mol Neurobiol 1998; 17: 73-86.
109. Loper-Jaramillo P, Teran E. Improvement in functions of the central nervous system by estrogen replacement therapy might be related with an increased nitric oxide production. Endothelium 1999; 6: 263-266.
110. Ruiz-Sanz JI, Navarro R, Martinez R, Martin C, Lacort M, Matorras R, Ruiz-Larrea MB. 17beta-estradiol affects in vivo the low density lipoprotein composition, particle size, and oxidizability. Free Radic Biol Med 2001; 31: 391-397.
111. Subbiah MT, Abplanalp W. Evidence of increased formation of products retaining strong antioxidant activity from estradiol-17beta oxidation in the presence of human plasma lipoproteins. J Lab Clin Med 2002; 139: 357-363.
112. Arteaga E, Villaseca P, Rojas A, Arteaga A, Bianchi M. Comparison of the antioxidant effect of estriol and estradiol on low density lipoproteins in postmenopausal women. Rev Med Clin 1998; 126: 481-487.
113. Reaven G. Metabolic syndrome: pathophysiology and implications for managment of cardiovascular disease. Circulation 2002; 106: 286-288.
114. Duplus E, Glorian M, Forest V. Fatty acid regulation of gene transcription. J Biol Chem 2000; 275: 30749-30752.
115. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
116. Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int 2000; 58: 26-30.
117. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production block three pathways of hyperglycaemic damage. Nature 2000; 404: 787-790.
118. Paolisso G, Gambardella A, Tagliamonte MR, Saccomanno F, Salvatore T, Gualdiero P, D'Onofrio MV, Howard BV. Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? J Clin Endocrinol Metab 1996; 81: 4244-4248.
119. Wojtczak L, Schonfeld P. Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta 1993; 1183: 41-57.
120. Pansini F, Bonaccorsi G, Genovesi F, Folegatti MR, Bagni B, Bergamini CM, Mollica G. Influence of estrogens on serum free fatty acids levels in women. J Clin Endocrinol Metab 1990; 71: 1387-1389.
121. Delmas P, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997; 337: 1641-1647.
122. Pansini F, Mollica G, Bergamini CM. Managment of the menopausal disturbances and oxidative stress. Curr Pharm Des 2005; 11: 2063-2073.
123. Wassmann S, Laufs U, Stamenkovic D, Linz W, Stasch JP, Ahlbory K, Rosen R, Bohm M, Nickenig G. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation 2002; 105: 2083-2091.
124. Maccarone M, Lorenzon T, Guerieri P, Finazzi-Agrò A. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cycloxygenase activity. Eur J Biochem 1999; 265: 27-34.
125. Appendino G, Spagliardi P, Cravotto G, Pocock V, Milligan S. Daucane phytoestrogens: a structure-activity study. J Nat Prod 2002; 65: 1612-1615.
126. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998; 91: 6-11.
127. Mackey R, Eden J. Phytoestrogens and the menopause. Climacteric 1998; 1: 302-308.
128. Adlercreutz H, Hamalainen E, Gorbach S, Goldin B. Dietary phyto-oestrogens and the menopause in Japan. Lancet 1992; 339: 1233.
129. Fotsis T, Pepper M, Montesano R, Aktas E, Breit S, Schweigerer L, Rasku S, Wahala K, Adlercreutz H. Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metab 1998; 12: 649-666.
130. Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 1998; 95: 3106-3110.
131. Samman S, Lyons Wall PM, Chan GS, Smith SJ, Petocz P. The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 1999; 147: 277-283.
132. Hernandez R, Mahedero G, Caballero MJ, Rodriguez J, Manjon I, Rodriguez I, Maynar M. Effects of physical excercise in pre-and post-menopausal women on lipid peroxidation and antioxidant systems. Endocr Res 1999; 25: 153-161.
133. Leal M, Diaz J, Serrano E, Abellan J, Carbonell LF. Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes. Obstet Gynecol 2000; 95: 804-809.
134. Christy C. Vitamin E in menopause. Am J Obstet Gynecol 1945; 50: 84-87.
135. McLaren H. Vitamin E in menopause. Br Med J 1949; 2: 1378-1381.
136. Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, Fidler P, Stella PJ, Swan DK, Vaught NL, Novotny P. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998; 16: 495-500.
137. Meydany M. Vitamin E. Lancet 1995; 345: 170-175.
138. Vina J, Borras C, Gambini J, Sastre J, Pallardo FV. Why female live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett 2005; 579: 2541-2545.
139. Kumaraguruparan R, Kabalimoorthy J, Nagini S. Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem 2005; 38: 154-158.
140. Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 2003; 31: 1441-1444.
141. Ray G, Husain SA. Oxidants, antioxidants and carcinogenesis. Indian J Exp Biol 2002; 40: 1213-1232.
142. Kang DH. Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues 2002; 13: 540-549.
143. Kumaraguruparan R, Subapriya R, Viswanathan P, Nagini S. Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast. Clin Chim Acta 2002; 325: 165-170.
144. Kumaraguruparan R, Subapriya R, Kabalimoorthy J, Nagini S. Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin Biochem 2002; 35: 275-279.
145. Kupka R, Msamanga GI, Spiegelman D, Morris S, Mugusi F, Hunter DJ, Fawzi WW. Selenium status is associated with accelerated HIV disease progression among HIV-I-infected pregnant women in Tanzania. J Nutr 2004; 134: 2556-2560.
146. Fawzi W, Msamanga G. Micronutrients and adverse pregnancy outcomes in the context of HIV infections. Nutr Rev 2004; 62: 269-275.
147. Mates M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000; 153: 83-104.
148. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Chen JM, Tsai CH. Glutathione S-transferase MI null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis. Mol Hum Reprod 2004; 10: 713-717.
149. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 2005; 3: 28.
150. Miquel J, Ramirez-Bosca A, Ramirez-Bosca JV, Alperi JD. Menopause: a review on the role of oxygen stress and favorable effects of dietary antioxidants. Arch Gerontol Geriatr 2006; 42: 289-306.
151. Upston JM, Kritharides L, Stocker R. The role of vitamin E in atherosclerosis. Prog Lipid Res 2003; 42: 405-22.
152. Jialal GL, Vega GL, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 1990; 82: 185-191.
153. Jialal I, Devaraj S, Kaul N. The effect of alpha-to-copherol on monocyte proatherogenic activity. Am J Clin Nutr 2001; 131: 389-394.
154. Offerman MK, Medford RM. Antioxidants and atherosclerosis, a molecular perspectives. Heart Dis Stroke 1994; 3: 52-57.
155. Vatassery GT, Lai JC, De Master EG, Smith WE. Oxidation of vitamin E and vitamin C and inhibition of brain mitochondria oxidative phosphorilation by peroxynitrite. J Neurosci Res 2004; 75: 845-853.
156. De la Fuente M, Ferrandez MD, Burgos MS, Soler A, Prieto A, Miquel J. Immune function in aged women is improved by ingestion of vitamin C and E. Can J Physiol Pharmacol 1998; 76: 373-380.
157. Viña JR, Sáez GT, Viña J. The physiological functions of glutathione. In: Miquel J, Quintanilha AT, Weber H, eds, Handbook of Free Radicals and Antioxidants in Biomedicine 2, CRC Press, Boca Raton, FL, 1989: pp 121-132.
158. Miquel J, Weber H. Aging and increased oxidation of the sulfur pool. In: Viña J, Editor, Glutathione: Metabolism and Physiological Functions, CRC Press, Boca Raton, FL, 1990: pp 187-192.
159. Harding JJ, Blakytni R, Ganea A. Glutathione in disease. Biochem Soc Trans 1996; 24: 881-884.
160. Chen TS, Richie JP Jr, Nagasawa HT, Lang CA. Glutathione monoethyl ester against glutathione deficiencies due to aging and acetaminophen in mice. Mech Ageing Dev 2000; 120: 127-139.
161. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Rad Biol Med 1995; 19: 227-250.
162. El Midaoui A, De Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by alpha lipoic acid. Hypertension 2002; 39: 303-307.
163. Weber H, Fleming JE, Miquel J. Thiazolidine-4-carboxylic acid, a physiologic sulphydryl antioxidant with potential value in geriatric medicine. Arch Gerontol Geriatr 1982; 1: 299-310.
164. Stohs SJ, El-Rashidy FH, Lawson T, Kobashi RH, Wulf BV, Potter JF. Changes in glutathione and glutathione metabolizing enzymes in human erythrocytes and lymphocytes as a function of age of donor. Age 1984; 7: 3-7.
165. De la Fuente M, Victor VM. Anti-oxidants as modulators of immune function. Immunol Cell Biol 2000; 78: 49-54.
166. Correa R, Blanco B, Del Río M, Victor V, Guayerbas N, Medina S. Effect of a diet supplemented with thioproline on murine macrophage function in a model of premature aging. Biofactors 1999; 10: 195-200.
167. Guayerbas N, Puerto M, Hernanz A, Miquel J, De la Fuente M. Thiolic antioxidant supplementation of the diet reverses age-related behavioral dysfunction in prematurely ageing mice. Pharmacol Biochem Behav 2005; 80: 45-51.
168. Redmon JB, Carey P, Pryor JL. Varicocele: the most common cause of male factor infertility? Hum Reprod Update 2002; 8: 53-58.
169. Semercioz A, Onur R, Ogras S, Orhan I. Effects of melatonin on testicular tissue oxide level and antioxidant enzyme activities in experimentally induced left varicocele. Neuroendocrinol Lett 2003; 24 :86-90.
170. Middendorf R, Muller D, Wichers S, Holstein AF, Davidoff MS. Evidence for production and functional activity of nitric oxide in seminiferous tubules and blood vessels of the human testis. J Clin Endocrinol Metab 1997; 82: 4154-4161.
171. Zini A, O'Bryan MK, Magid MS, Schlegel PN. Immunohistochemical localization of endothelial nitric oxide synthase in human testis, epididymis, and vas deferens suggests a possible role for nitric oxide in spermatogenesis, sperm maturation, and programmed cell death. Biol Reprod 1996; 55: 935-941.
172. Rosselli M, Keller PJ, Dubej RK. Role of nitric oxide in the biology, physiology and pathophysiology of reproduction. Hum Reprod Update 1998; 4: 3-24.
173. Rosselli M, Dubey R, Imthurn B, Macas E, Keller PJ. Effect of nitric oxide on human spermatozoa: evidence that nitric oxide decreases sperm motility and induces sperm toxicity. Hum Reprod 1995; 10: 1786-1790.
174. Del Punta K, Charreau AH, Pignataro OP. Nitric oxide inhibits Leydig cell steroidogenesis. Endocrinology 1996; 137: 5337-5343.
175. Aksoy H, Aksoy Y, Ozbey I, Altuntas I, Akcay F. The relationship between varicocele and semen nitric oxide concentrations. Urol Res 2000; 28: 357-359.
176. Ozbek E, Turkoz Y, Gokdeniz R, Davarci M, Ozugurlu F. Increased nitric oxide production in the spermatic vein of patients with varicocele. Eur Urol 2000; 37: 172-175.
177. Santoro G, Romeo C, Impellizzeri P, Ientile R, Cutroneo G, Trimarchi F, Pedale S, Turiaco N, Gentile C. Nitric oxide synthase patterns in normal and varicocele testis in adolescents. BJU Int 2001; 88: 967-973.
178. Romeo C, Ientile R, Impellizzeri P, Turiaco N, Teletta M, Antonuccio P, Basile M, Gentile C. Preliminary report on nitric oxide-mediated oxidative damage in adolescent varicocele. Hum Reprod 2003; 18: 26-29.
179. Koksal T, Erdogru T, Toptas B, Gulkesen KH, Usta M, Baykal A, Baykara M. Effect of experimental varicocele in rats on testicular oxidative stress status. Andrologia 2002; 34: 242-244.
180. De Stefani S, Silingardi V, Micali S, Mofferdin A, Sighinolfi MC, Celia A, Bianchi G, Giulini S, Volpe A, Giusti F, Maiorana A. Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. Andrologia 2005; 37: 115-118.
181. Koltuksuz U, Irmak MK, Karaman A, Uz E, Var A, Ozyurt H, Akyol O. Testicular nitric oxide levels after unilateral testicular torsio/ detorsion in rats pretreated with caffeic acid phenethyl ester. Urol Res 2000; 28: 360-363.
182. Baud L, Ardaillou R. Reactive oxygen species: production and role in the kidney. Am J Physiol 1986; 251: 765-776.
183. Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 1989; 35: 1093-1106.
184. Greene EL, Paller MS. Oxygen free radicals in acute renal failure. Miner Electrolyte Metab 1991; 17: 124-132.
185. Baud L, Fouqueray B, Philippe C, Ardaillou R. Reactive oxygen species as glomerular autacoids. J Am Soc Nephrol 1992; 2: 132-138.
186. Baud L, Ardaillou R. Involvement of reactive oxygen species in kidney damage. Br Med Bull 1993; 49: 621-629.
187. Paller MS, Neumann TV. Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygeneration. Kidney Int 1991; 40: 1041-1049.
188. Nath KA, Paller MS. Dietary deficiency of antioxidants exacerbates ischemic injury in the rat kidney. Kidney Int 1990; 38: 1109-1117.
189. Yoshihoka T, Ichikawa I, Fogo A. Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 1991; 2: 902-912.
190. Rehan A, Johnson KJ, Wiggins RC, Kunkel RG, Ward PA. Evidence for the role of oxygen radicals in acute nephrotoxic nephritis. Lab Invest 1984; 51: 396-403.
191. Baud L, Hagege J, Sraer J, Rondeau E, Perez J, Ardaillou R. Reactive oxygen production by cultured rat glomerular mesangial cells during phagocytosis is associated with stimulation of lipoxygenase activity. J Exp Med 1983; 158: 1836-1852.
192. Radeke HH, Cross AR, Hanonck JT, Jones OT, Nakamura M, Kaever V, Resch K. Functional expression of NADPH oxidase components (a and b-subunits of cytochrome b558 and 45-kDA flavoprotein) by intrinsic human glomerular mesangial cells. J Biol Chem 1991; 266: 21025-21029.